A Business at a Glance
0 of 1 daily views used (1 remaining). Sign up free for +5 more daily views (6 total), or try AAPL for a full preview.
CNL Healthcare Properties, Inc.
CHTH
CNL Healthcare Properties, Inc. (CHTH) has a 5-year average return on invested capital (ROIC) of 1.0%. This is below average and may indicate limited pricing power.
CNL Healthcare Properties, Inc. (CHTH) has a market capitalization of $876M. It is classified as a small-cap stock.
Yes, CNL Healthcare Properties, Inc. (CHTH) pays a dividend with a trailing twelve-month yield of 2.03%.
CNL Healthcare Properties, Inc. (CHTH) operates in the Real Estate Investment Trusts industry, within the Real Estate sector.
CNL Healthcare Properties, Inc. (CHTH) reported annual revenue of $366 million in its most recent fiscal year, based on SEC EDGAR filings.
CNL Healthcare Properties, Inc. (CHTH) has a net profit margin of -4.0%. The company is currently unprofitable.
CNL Healthcare Properties, Inc. (CHTH) generated $24 million in free cash flow in its most recent fiscal year. Positive free cash flow supports dividends, buybacks, and debt reduction.
CNL Healthcare Properties, Inc. is a Maryland corporation that elected to be taxed as a REIT for U.S. federal income tax purposes. We have been and intend to continue to be organized and operate in a manner that allows us to remain qualified as a REIT for U.S. federal income tax purposes. The terms “us,” “we,” “our,” “Company” and “CNL Healthcare Properties” include CNL Healthcare Properties, Inc. and each of its subsidiaries. Substantially all of our assets are held by, and all operations are conducted, either directly or indirectly, through: (1) CHP Partners LP (“Operating Partnership”) in which we are the sole limited partner and our wholly owned subsidiary, CHP GP, LLC, is the sole general partner; (2) a wholly owned taxable REIT subsidiary (“TRS”), CHP TRS Holding, Inc.; (3) property owner subsidiaries and lender subsidiaries, which are single purpose entities; and (4) through November 1, 2024, an investment in a consolidated joint venture.
| Metric | TTM | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Revenue | 385M | 366M | 341M | 323M | 295M | 307M |
| Net Income | -11M | -14M | -26M | -1.5M | -23M | 3.9M |
| EPS | $-0.06 | $-0.08 | $-0.15 | $-0.01 | $-0.13 | $0.01 |
| Free Cash Flow | 35M | 24M | 16M | 26M | 32M | 51M |
| ROIC | 4.6% | 2.1% | 0.8% | 0.3% | - | 0.9% |
| Gross Margin | 32.8% | 19.1% | 16.0% | 12.9% | 16.1% | 20.2% |
| Debt/Equity | 0.00 | 1.57 | 1.52 | 1.46 | 1.35 | 1.08 |
| Dividends/Share | $0.10 | $0.10 | $0.10 | $0.10 | $0.20 | $0.20 |
| Operating Income | 34M | 31M | 14M | 8.9M | - | 22M |
| Operating Margin | 8.8% | 8.4% | 4.0% | 2.7% | - | 7.1% |
| ROE | -1.5% | -2.0% | -3.5% | -0.2% | -2.8% | 0.5% |
| Shares Outstanding | 175M | 181M | 171M | 145M | 176M | 174M |
| Metric | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||||
| Revenue | 53M | 181M | 301M | 377M | 285M | 312M | 326M | 307M | 295M | 323M | 341M | 366M | 385M |
| Gross Margin | 28.3% | 13.5% | 14.9% | 18.4% | 19.5% | 24.4% | 26.9% | 20.2% | 16.1% | 12.9% | 16.0% | 19.1% | 32.8% |
| R&D | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| SG&A | 5.6M | 6.9M | 10M | 13M | 12M | 13M | 13M | 9.4M | 9.1M | 10M | 9.1M | 8.8M | 9.6M |
| EBIT | -14M | -23M | -24M | 11M | 31M | 24M | N/A | 22M | N/A | 8.9M | 14M | 31M | 34M |
| Op. Margin | -26.6% | -12.8% | -8.1% | 3.0% | 10.9% | 7.7% | N/A | 7.1% | N/A | 2.7% | 4.0% | 8.4% | 8.8% |
| Net Income | -18M | -53M | -68M | -32M | -26M | -25M | 351M | 3.9M | -23M | -1.5M | -26M | -14M | -11M |
| Net Margin | -34.4% | -29.0% | -22.6% | -8.4% | -9.1% | -8.0% | 107.8% | 1.3% | -7.7% | -0.5% | -7.5% | -4.0% | -2.7% |
| Non-Recurring | 0 | 0 | 9.3M | 9.3M | 9.3M | 16M | 7.9M | 12M | 20M | 0 | 0 | 0 | 0 |
| Returns on Capital | |||||||||||||
| ROIC | -2.7% | -3.6% | -2.5% | 0.3% | 1.0% | 1.0% | N/A | 0.9% | N/A | 0.3% | 0.8% | 2.1% | 4.6% |
| ROE | -6.1% | -7.9% | -5.4% | -2.7% | -2.5% | -2.7% | 39.1% | 0.5% | -2.8% | -0.2% | -3.5% | -2.0% | -1.5% |
| ROA | -2.7% | -3.5% | -2.4% | -1.1% | -0.9% | -0.9% | 21.7% | 0.3% | -1.6% | -0.1% | -1.9% | -1.1% | -0.8% |
| Cash Flow | |||||||||||||
| Op. Cash Flow | 3.0M | 19M | 44M | 75M | 75M | 67M | 60M | 63M | 46M | 44M | 32M | 40M | 53M |
| Free Cash Flow | -653M | -850M | -823M | 46M | 74M | 57M | 54M | 51M | 32M | 26M | 16M | 24M | 35M |
| Owner Earnings | -14M | -44M | -62M | -48M | 11M | 13M | 10M | 11M | -4.1M | -10M | -19M | -10M | 2.5M |
| CapEx | 656M | 869M | 866M | 28M | 1.1M | 9.8M | 6.4M | 12M | 14M | 18M | 16M | 16M | 18M |
| Maint. CapEx | 17M | 63M | 106M | 123M | 64M | 54M | 50M | 52M | 50M | 54M | 51M | 51M | 51M |
| Growth CapEx | 639M | 806M | 760M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| D&A | 17M | 63M | 106M | 123M | 64M | 54M | 50M | 52M | 50M | 54M | 51M | 51M | 51M |
| CapEx/OCF | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | 34.1% |
| Capital Allocation | |||||||||||||
| Dividends Paid | 6.6M | 14M | 26M | 31M | 35M | 59M | 395M | 36M | 36M | 18M | 18M | 18M | 18M |
| Dividend Yield | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | 2.0% |
| Share Buybacks | 706K | 2.2M | 7.4M | 29M | 46M | 40M | 23K | 23K | 0 | 0 | 0 | 0 | 0 |
| Buyback Yield | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | 0.0% |
| Stock-Based Comp | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Debt Repayment | 0 | 0 | 0 | 1.1M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Balance Sheet | |||||||||||||
| Net Debt | 591M | 1.2B | 2.2B | 2.4B | 2.1B | 1.4B | 973M | 816M | 986M | 1.0B | 1.0B | 1.0B | -115M |
| Cash & Equiv. | 44M | 91M | 69M | 59M | 65M | 57M | 42M | 61M | 53M | 70M | 54M | 44M | 115M |
| Long-Term Debt | 537M | 1.1B | 1.5B | 1.6B | 1.7B | 960M | 682M | 603M | 593M | 610M | 585M | 570M | 570M |
| Debt/Equity | 1.41 | 1.45 | 1.86 | 2.19 | 2.10 | 1.59 | 1.18 | 1.08 | 1.35 | 1.46 | 1.52 | 1.57 | 0.00 |
| Interest Coverage | -1.3 | -0.8 | -0.6 | 0.2 | 0.9 | 0.6 | N/A | 0.9 | N/A | 0.4 | 0.3 | 0.7 | 0.8 |
| Equity | 452M | 871M | 1.3B | 1.2B | 1.1B | 940M | 899M | 868M | 809M | 790M | 744M | 712M | 694M |
| Total Assets | 1.0B | 2.0B | 2.8B | 2.8B | 2.8B | 2.7B | 1.6B | 1.5B | 1.4B | 1.4B | 1.4B | 1.3B | 1.3B |
| Total Liabilities | 562M | 1.1B | 1.6B | 1.7B | 1.7B | 1.8B | 715M | 635M | 626M | 647M | 621M | 608M | 608M |
| Intangibles | 52M | 140M | 172M | 131M | 4.1M | 1.6M | 1.2M | 826K | 432K | 1.2M | 104K | N/A | N/A |
| Retained Earnings | -31M | -83M | -151M | -183M | -209M | -234M | 121M | 125M | 102M | 100M | 75M | 60M | 55M |
| Working Capital | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | -30M |
| Current Assets | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | 2.4M |
| Current Liabilities | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | 31M | N/A | 32M |
| Per Share Data | |||||||||||||
| EPS | -0.42 | -0.61 | -0.44 | -0.18 | -0.11 | -0.12 | 0.01 | 0.01 | -0.13 | -0.01 | -0.15 | -0.08 | -0.06 |
| Owner EPS | -0.32 | -0.51 | -0.40 | -0.28 | 0.05 | 0.06 | 0.06 | 0.06 | -0.02 | -0.07 | -0.11 | -0.06 | 0.01 |
| Book Value | 10.49 | 10.12 | 8.13 | 6.55 | 4.45 | 4.50 | 5.17 | 4.99 | 4.60 | 5.44 | 4.34 | 3.94 | 3.96 |
| Cash Flow/Share | 0.07 | 0.22 | 0.28 | 0.42 | 0.32 | 0.32 | 0.34 | 0.36 | 0.26 | 0.30 | 0.19 | 0.22 | 0.23 |
| Dividends/Share | 0.40 | 0.41 | 0.42 | 0.42 | 0.44 | 0.47 | 2.27 | 0.20 | 0.20 | 0.10 | 0.10 | 0.10 | 0.10 |
| Shares Out. | 43.1M | 86.1M | 154.7M | 175.9M | 236.0M | 208.9M | 174.0M | 174.0M | 176.0M | 145.3M | 171.3M | 180.8M | 175.3M |
| Valuation | |||||||||||||
| P/E Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | -83.3 |
| P/FCF | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | 25.0 |
| EV/EBIT | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | 22.5 |
| Price/Book | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | 1.3 |
| Price/Sales | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | 2.3 |
| FCF Yield | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | 4.0% |
| Market Cap | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | 876M |
| Avg. Price | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | 5.00 |
| Year-End Price | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | 5.00 |
CNL Healthcare Properties, Inc. passes 1 of 9 quality checks, indicating weak fundamentals.
The company's 5-year average ROIC is 1.0% with a gross margin of 16.8%. Total shareholder yield (dividends) is 2.0%.
CNL Healthcare Properties, Inc. (CHTH) has a debt-to-equity ratio of 1.57. This indicates higher leverage, which may increase financial risk.
CNL Healthcare Properties, Inc. (CHTH) reported earnings per share (EPS) of $-0.08 in its most recent fiscal year.
CNL Healthcare Properties, Inc. (CHTH) has a return on equity (ROE) of -2.0%. A negative ROE may indicate losses or negative equity.
CNL Healthcare Properties, Inc. (CHTH) has a 5-year average gross margin of 16.8%. This lower margin is typical of capital-intensive or commodity businesses.
The Ledger Terminal provides 14 years of financial data for CNL Healthcare Properties, Inc. (CHTH), sourced directly from SEC EDGAR filings. This includes income statements, balance sheets, cash flow statements, and key financial ratios.
CNL Healthcare Properties, Inc. (CHTH) has a book value per share of $3.94, based on its most recent annual SEC filing.